loader
Please Wait
Applying Filters...
FDA_Warning_Letters, Import_Alerts_&_EU_Non-Compliances_in_2019
X

Swedish Orphan Biovitrum Ab's list of EU CTD Dossiers, Marketing Authorizations, In, Out Licensing Opportunities & Finished Dosage Formulations aggregated by PharmaCompass

Client EmailClient Virtual Booth
Filters Filter
×
FILTER DATA :

filter

BIOVITRUM AB

SWEDISH ORPHAN

SWEDISH ORPHAN BIOVITRUM AB (PUBL)

filter

ANAKINRA

NITISINONE

PALIFERMIN

filter

CAPSULE

CAPSULE;ORAL

INJECTABLE; INJECTION

SOLUTION

SUSPENSION

SUSPENSION;ORAL

VIAL; SUBCUTANEOUS

filter

10MG

10MIU/VIAL

150MG/ML

18MIU/VIAL

20MG

25MIU/VIAL

2MG

4MG/ML

5MG

60MCG/KG/DAY

filter

CANADA

USA

VIAL; SUBCUTANEOUS
10MIU/VIAL
KINERET
USA
103950
VIAL; SUBCUTANEOUS
18MIU/VIAL
KINERET
USA
103950
VIAL; SUBCUTANEOUS
25MIU/VIAL
KINERET
USA
103950
SOLUTION
150MG/ML
KINERET
CANADA
2245913
0.67 ML
Prescription
CAPSULE;ORAL
2MG
ORFADIN
USA
21232
2002-01-18
RX
CAPSULE;ORAL
5MG
ORFADIN
USA
21232
2002-01-18
RX
CAPSULE;ORAL
10MG
ORFADIN
USA
21232
2002-01-18
RX
CAPSULE;ORAL
20MG
ORFADIN
USA
21232
2016-06-13
RX
SUSPENSION;ORAL
4MG/ML
ORFADIN
USA
206356
2016-04-22
RX
CAPSULE
5MG
ORFADIN
CANADA
2459701
60
Prescription
CAPSULE
10MG
ORFADIN
CANADA
2459728
60
Prescription
CAPSULE
20MG
ORFADIN
CANADA
2459736
60
Prescription
CAPSULE
2MG
ORFADIN
CANADA
2459698
60
Prescription
SUSPENSION
4MG/ML
ORFADIN
CANADA
2469693
90ML
Prescription
INJECTABLE; INJECTION
60MCG/KG/DAY
KEPIVANCE
USA
125103

PharmaCompass >>

First
Previous
Next
Last